Interest in Cessation Treatment Among People Who Smoke in a Community-Based Multidisciplinary Thoracic Oncology Program.

Lung cancer Multidisciplinary care Smoking cessation Tobacco cessation services

Journal

JTO clinical and research reports
ISSN: 2666-3643
Titre abrégé: JTO Clin Res Rep
Pays: United States
ID NLM: 101769967

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 10 02 2021
revised: 13 04 2021
accepted: 23 04 2021
entrez: 30 9 2021
pubmed: 1 10 2021
medline: 1 10 2021
Statut: epublish

Résumé

To evaluate the need for tobacco cessation services within a multidisciplinary clinic (MDC), we surveyed patients on their smoking status, interest in quitting, and willingness to participate in a clinic-based cessation program. We further evaluated the association between interest in cessation or willingness to participate in a cessation program and overall survival (OS). From 2014 to 2019, all new patients with lung cancer in the MDC at Baptist Cancer Center (Memphis, TN) were administered a social history questionnaire to evaluate their demographic characteristics, smoking status, tobacco dependence, interest in quitting, and willingness to participate in a cessation program. We used chi-square tests and logistic regression to compare characteristics of those who would participate to those who would not or were unsure and Kaplan-Meier curves and Cox regression to evaluate the association between cessation interest or willingness to quit and OS. Of 641 total respondents, the average age was 69 years (range: 32-95), 47% were men, 64% white, 34% black, and 17% college graduates. A total of 90% had ever smoked: 34% currently and 25% quit within the past year. Among the current smokers, 60% were very interested in quitting and 37% would participate in a cessation program. Willingness to participate in a cessation program was associated with greater interest in quitting ( Patients with lung cancer in an MDC expressed considerable interest in tobacco cessation services; patients willing to participate in a clinic-based cessation program had improved survival.

Identifiants

pubmed: 34590029
doi: 10.1016/j.jtocrr.2021.100182
pii: S2666-3643(21)00041-2
pmc: PMC8474282
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100182

Subventions

Organisme : NCI NIH HHS
ID : UG1 CA189873
Pays : United States

Informations de copyright

© 2021 The Authors.

Références

Addict Behav. 1997 Nov-Dec;22(6):727-39
pubmed: 9426790
Lancet Oncol. 2014 Nov;15(12):e568-80
pubmed: 25439699
Br J Cancer. 2017 Oct 10;117(8):1224-1232
pubmed: 28898236
Lung Cancer. 2006 Sep;53(3):375-80
pubmed: 16814423
Oncology. 2010;78(5-6):289-301
pubmed: 20699622
Radiother Oncol. 2011 Dec;101(3):495-501
pubmed: 21737169
Cancer. 2011 Jul 1;117(13):2961-9
pubmed: 21692055
J Thorac Oncol. 2018 May;13(5):603-605
pubmed: 29703537
JCO Oncol Pract. 2020 Jun;16(6):e549-e556
pubmed: 32048929
Ann Intern Med. 1993 Sep 1;119(5):383-90
pubmed: 8393311
Am J Clin Oncol. 1982 Dec;5(6):649-55
pubmed: 7165009
Transl Lung Cancer Res. 2018 Feb;7(1):88-102
pubmed: 29535915
Cancer. 1995 Jan 15;75(2):569-76
pubmed: 7812925
J Clin Oncol. 2002 Sep 1;20(17):3651-7
pubmed: 12202666
Addict Behav. 2007 May;32(5):1031-42
pubmed: 16930848
Transl Lung Cancer Res. 2015 Aug;4(4):456-64
pubmed: 26380187
BMJ Support Palliat Care. 2012 Dec;2(4):312-8
pubmed: 24654214
Nicotine Tob Res. 2010 Oct;12 Suppl:S4-11
pubmed: 20889479
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Chest. 2006 Dec;130(6):1784-90
pubmed: 17166997
BMJ. 2010 Jan 21;340:b5569
pubmed: 20093278
Clin Cancer Res. 2013 Apr 15;19(8):1941-8
pubmed: 23570694
Am J Epidemiol. 1993 Dec 1;138(11):923-36
pubmed: 8256780
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Pharmacotherapy. 2012 Oct;32(10):920-31
pubmed: 23033231
J Clin Oncol. 2021 Mar 10;39(8):876-880
pubmed: 33439692
J Oncol Pract. 2013 Sep;9(5):258-62
pubmed: 23943904
Oncol Nurs Forum. 2008 Sep;35(5):745-7
pubmed: 18765319
J Clin Oncol. 2002 Aug 15;20(16):3461-9
pubmed: 12177107
Am Soc Clin Oncol Educ Book. 2013;:359-64
pubmed: 23714547
Cancer. 2014 Feb 15;120(4):562-9
pubmed: 24496870
Cancer Causes Control. 2021 Mar;32(3):311-316
pubmed: 33496899
Cancer. 2014 Dec 1;120(23):3617-26
pubmed: 25043526
J Clin Oncol. 2013 Sep 1;31(25):3147-57
pubmed: 23897958
Oncol Nurs Forum. 1997 Sep;24(8):1419-22
pubmed: 9380597
Br J Addict. 1989 Jul;84(7):791-9
pubmed: 2758152
Epidemiology. 1990 Jan;1(1):43-6
pubmed: 2081237
J Pain. 2009 Mar;10(3):323-8
pubmed: 19254679
Transl Lung Cancer Res. 2015 Aug;4(4):339-52
pubmed: 26380175
J Thorac Oncol. 2015 Nov;10(11):1532-7
pubmed: 26317914
J Thorac Oncol. 2015 Jul;10(7):1014-9
pubmed: 26102442
J Oncol Pract. 2016 Nov;12(11):983-991
pubmed: 27650844
Ann Thorac Surg. 2016 May;101(5):1644-5
pubmed: 27106412
Cancer. 2003 Aug 1;98(3):632-44
pubmed: 12879483
Transl Lung Cancer Res. 2019 May;8(Suppl 1):S50-S58
pubmed: 31211105
Psychooncology. 2004 May;13(5):346-58
pubmed: 15133775
Addiction. 2015 Mar;110(3):381-6
pubmed: 25323093

Auteurs

Meghan Meadows-Taylor (M)

Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.

Kenneth D Ward (KD)

Division of Social & Behavioral Sciences, School of Public Health, The University of Memphis, Memphis, Tennessee.

Weiyu Chen (W)

Division of Social & Behavioral Sciences, School of Public Health, The University of Memphis, Memphis, Tennessee.

Nicholas R Faris (NR)

Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.

Carrie Fehnel (C)

Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.

Meredith A Ray (MA)

Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, The University of Memphis, Memphis, Tennessee.

Folabi Ariganjoye (F)

Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.

Courtney Berryman (C)

Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.

Cheryl Houston-Harris (C)

Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.

Laura M McHugh (LM)

Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.

Alicia Pacheco (A)

Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.

Raymond U Osarogiagbon (RU)

Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.

Classifications MeSH